Clinical reference Biomarker Directory
Back to directory

Perineuclear Antineutrophil Cytoplasmic Antibodies

Established

p-ANCA is an immunofluorescence pattern typically corresponding to MPO-ANCA, associated with specific vasculitis subtypes.

Also known as p-ANCA MPO-ANCA (perinuclear pattern)
In plain language

This is a specific staining pattern of the ANCA antibody test, usually pointing toward one type of small-vessel vasculitis rather than another, though the same antibody pattern can also show up in some digestive and liver diseases.

Biomarker & context

Perinuclear ANCA (p-ANCA) refers to a specific immunofluorescence staining pattern of antineutrophil cytoplasmic antibodies, usually corresponding to antibodies against myeloperoxidase (MPO-ANCA).

What it indicates

The p-ANCA/MPO-ANCA pattern is associated with microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis, distinguishing it from the cytoplasmic (c-ANCA/PR3-ANCA) pattern more typical of granulomatosis with polyangiitis; p-ANCA can also be seen in inflammatory bowel disease and autoimmune hepatitis.

Diagnosis & clinical testing

Measured via indirect immunofluorescence (determining the staining pattern) combined with antigen-specific immunoassay (confirming MPO or PR3 specificity), since immunofluorescence pattern and antigen specificity don't always perfectly correlate.

Guiding treatment

As with ANCA testing generally (discussed earlier), a compatible clinical presentation with positive p-ANCA/MPO-ANCA serology often supports starting treatment for vasculitis without waiting for kidney biopsy confirmation in rapidly deteriorating patients, per current KDIGO 2024 guidance.

Clinical significance

Distinguishes from the cytoplasmic (c-ANCA/PR3) pattern more typical of granulomatosis with polyangiitis.

References
  1. KDIGO. (2024). Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis.